HOME > TOP STORIES
TOP STORIES
-
BUSINESS Chugai Files Actemra for COVID-19 Pneumonia in Japan
December 14, 2021
-
REGULATORY METI to Dole Out Support for “Dual-Use” Production Bases to Boost Pandemic Preparedness
December 13, 2021
-
REGULATORY Fiscal Discipline for Drug Spending Could Be Discussed towards FY2023: MOF Budget Examiner
December 10, 2021
-
REGULATORY E Keppra Generics from 12 Firms to Join NHI Price List, Patanol and Velcade AGs Too
December 9, 2021
-
ACADEMIA With First Ophthalmologic Biosimilar Set to Debut, Specialist Says Close Attention Required for Unexpected Side Effects
December 9, 2021
-
REGULATORY Moderna COVID-19 Booster Up for Panel Review on Dec. 15
December 9, 2021
-
REGULATORY MHLW Warns against Hoarding on 17 APIs as Hitachi Fire Stirs Supply Worries
December 8, 2021
-
BUSINESS EU Panel Backs Tocilizumab for Severe COVID-19: Chugai
December 8, 2021
-
BUSINESS Horizon Plants Flag in Japan Soil to Gear Up for Thyroid Eye Disease Trial
December 7, 2021
-
REGULATORY BMS’ Second CAR-T Therapy Ide-Cel in Line for Approval in January
December 7, 2021
-
BUSINESS Towa Bags Approval of Edirol AG through Partial Change of Its Version
December 7, 2021
-
REGULATORY Panel OKs Outline of Emergency Approval System Based on “Presumed” Efficacy
December 6, 2021
-
REGULATORY MOF Panel’s Budget Proposal Pushes Macroeconomic Indexing, No Adjustment Rate
December 6, 2021
-
BUSINESS MSD Files Oral COVID-19 Drug in Japan
December 3, 2021
-
REGULATORY Average NHI-Market Price Gap of Listed Drugs at 7.6%: MHLW
December 3, 2021
-
REGULATORY Chuikyo Members Call for Restrictions in Re-Pricing Exclusions from Spillover Rule
December 2, 2021
-
BUSINESS Blaze at Hitachi Logistic Center Could Add to Drug Supply Woes
December 1, 2021
-
REGULATORY Japan Confirms 1st Case of Omicron Variant: MHLW
December 1, 2021
-
REGULATORY Alzheimer’s Drugs in Mind, MHLW to Float New Rule for Potential Super Big Sellers
November 30, 2021
-
BUSINESS Takeda’s GI Biz Poised for Growth with 3 Products Now in Its Lineup
November 29, 2021
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
